Zhao Hongfei, a reporter of Shenzhen Business Daily
On November 5th, the team of academician Zhong Nanshan went to Shenzhen People's Hospital for exchange and guidance. In view of the current situation of the "reinforcing needle" of the new crown vaccine, Academician Zhong Nanshan said that it is very necessary to take the third "reinforced injection".
He said that the third "reinforcing injection" is necessary to prevent infection and prevent aggravation of the disease, and now the most critical issue is the vaccination of the elderly. He said that the vaccination rate of the elderly is lower than that of adults and children, but they are at higher risk of getting sick, so it is necessary to strengthen the vaccination of the elderly before the end of this year, and strive to achieve more than 80% of the people to complete the full vaccination by the end of this year.
Zhong Nanshan said that the current vaccination situation of children aged 3-11 is good, but the vaccination rate of the elderly group is relatively low, the elderly group is the main target of infection, and the new crown virus will be more active after entering the winter, and it is necessary to strengthen the vaccination rate of the elderly group.
It is understood that Academician Zhong Nanshan visited Shenzhen People's Hospital this time, mainly to guide the development plan of the national clinical key specialties of the hospital and build a first-class discipline in the country. At the same time, he put forward opinions on the next step of the "three projects" team.
In November 2014, relying on the "three projects" of Shenzhen medical and health care, Shenzhen People's Hospital "held hands" with the Zhong Nanshan team of guangzhou Institute of Respiratory Diseases, and the academician team of Zhong Nanshan was the first batch of "three projects" team of Shenzhen People's Hospital.
In July 2021, Academician Zhong Nanshan was appointed as the honorary director of the Institute of Respiratory Diseases of Shenzhen People's Hospital. The institute was established in September 2015 and was awarded the National Clinical Key Specialty in 2021. At present, there are 3 general wards, 1 ricu (respiratory intensive care unit), 1 clinical function department, 3 municipal key laboratories, and the annual outpatient volume exceeds 100,000 people.
Review: Yu Fanghua